Hepatology Communications (Sep 2021)

The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity

Yue Shen,
William Eades,
Bingfang Yan

Affiliations

Yue Shen: Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy University of Cincinnati Cincinnati OH USA
William Eades: Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy University of Cincinnati Cincinnati OH USA
Bingfang Yan: Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy University of Cincinnati Cincinnati OH USA

DOI: https://doi.org/10.1002/hep4.1736
Journal volume & issue: Vol. 5, no. 9
pp. 1622 – 1623

Abstract

No abstracts available.

Published in Hepatology Communications

ISSN: 2471-254X (Online)
Publisher: Wolters Kluwer Health/LWW
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://journals.lww.com/hepcomm/pages/default.aspx

About the journal